Anti-Human IgG antibody [KT131],Abcam,AB211339

What is this antibody validated in? Anti-Human IgG antibody [KT131] (ab211339) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), ELISA in Human, samples.

Host

Mouse

Reactivity

Human

Application

ELISA, sELISA, WB

Platform ID

BAB782847255

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-Human IgG antibody [KT131]
Cat. No.AB211339
HostMouse
IsotypeIgG2a
ReactivityHuman
ApplicationELISA, sELISA, WB
ClonalityMonoclonal
Clone NumberKT131
Concentration0.75 mg/mL Batch dependent concentration
ImmunogenFull Length Protein corresponding to Human IGHG1. The exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationPreservative: 0.09% Sodium azide Constituents: PBS
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells. See full target information IGHG1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.